The Global Alzheimer Drugs Market reached US$ 4.46 billion in 2023 and is expected to reach US$ 18.33 billion by 2031, growing at a CAGR of 19.4% during the forecast period 2024-2031.
The Global Alzheimer Drugs Market scope includes drugs types of Alzheimer’s drugs such as rivastigmine, donepezil or galantamine, leading to a surge in Alzheimer’s drugs market share. Furthermore, the usage of biomarkers for drug discovery is significantly increasing and is being highly researched by researchers.